Christina A Rostad1,2, Alexander N Maillis3, Kristina Lai3, Nitya Bakshi3,4, Robert C Jerris5,6, Peter A Lane3,4, Marianne E Yee3,4, Inci Yildirim1,2,7. 1. Department of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia. 2. Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia. 3. Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia. 4. Department of Pediatrics, Division of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia. 5. Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia. 6. Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia. 7. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Abstract
BACKGROUND: Although respiratory syncytial virus (RSV) is the leading cause of pediatric lower respiratory tract infections, the burden of RSV in children with sickle cell disease (SCD) is unknown. METHODS: We conducted a retrospective, nested, case-control study of children with SCD <18 years who had respiratory viral panels (RVPs) performed at Children's Healthcare of Atlanta from 2012 to 2019. We abstracted the medical records to describe the demographics, clinical features, and outcomes of children who tested positive for RSV (cases) versus children who tested negative (controls). We calculated the annual incidence of RSV and related hospitalization rates with 95% confidence intervals (CIs) and used multivariate logistic regression to evaluate associations. RESULTS: We identified 3676 RVP tests performed on 2636 patients over seven respiratory seasons resulting in 219/3676 (6.0%) RSV-positive tests among 160/2636 (6.1%) patients. The average annual incidence of laboratory-confirmed RSV infection among children with SCD was 34.3 (95% CI 18.7-49.8) and 3.8 (95% CI 0.5-7.0) cases per 1000 person-years for those <5 years and 5-18 years, respectively. The RSV-related hospitalization rate for children <5 years was 20.7 (95% CI 8.5-32.8) per 1000 person-years. RSV-positive cases were significantly younger than RSV-negative patients (3.8 years vs 7.6 years, P < .001). Of RSV-positive cases, 22 (13.8%) developed acute chest syndrome and nine (5.6%) required intensive care, which was not significantly different from RSV-negative children with SCD. CONCLUSION: RSV infections are common in children with SCD with higher burden in younger patients. RSV is associated with considerable morbidity, including higher rates of hospitalization compared to the general population.
BACKGROUND: Although respiratory syncytial virus (RSV) is the leading cause of pediatric lower respiratory tract infections, the burden of RSV in children with sickle cell disease (SCD) is unknown. METHODS: We conducted a retrospective, nested, case-control study of children with SCD <18 years who had respiratory viral panels (RVPs) performed at Children's Healthcare of Atlanta from 2012 to 2019. We abstracted the medical records to describe the demographics, clinical features, and outcomes of children who tested positive for RSV (cases) versus children who tested negative (controls). We calculated the annual incidence of RSV and related hospitalization rates with 95% confidence intervals (CIs) and used multivariate logistic regression to evaluate associations. RESULTS: We identified 3676 RVP tests performed on 2636 patients over seven respiratory seasons resulting in 219/3676 (6.0%) RSV-positive tests among 160/2636 (6.1%) patients. The average annual incidence of laboratory-confirmed RSV infection among children with SCD was 34.3 (95% CI 18.7-49.8) and 3.8 (95% CI 0.5-7.0) cases per 1000 person-years for those <5 years and 5-18 years, respectively. The RSV-related hospitalization rate for children <5 years was 20.7 (95% CI 8.5-32.8) per 1000 person-years. RSV-positive cases were significantly younger than RSV-negative patients (3.8 years vs 7.6 years, P < .001). Of RSV-positive cases, 22 (13.8%) developed acute chest syndrome and nine (5.6%) required intensive care, which was not significantly different from RSV-negative children with SCD. CONCLUSION: RSV infections are common in children with SCD with higher burden in younger patients. RSV is associated with considerable morbidity, including higher rates of hospitalization compared to the general population.
Authors: Jo Howard; Nicholas Hart; Marilyn Roberts-Harewood; Michelle Cummins; Moji Awogbade; Bernard Davis Journal: Br J Haematol Date: 2015-03-30 Impact factor: 6.998
Authors: E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci Journal: N Engl J Med Date: 2000-06-22 Impact factor: 91.245
Authors: Lone Graff Stensballe; Kim Kristensen; Eric A F Simoes; Henrik Jensen; Jens Nielsen; Christine Stabell Benn; Peter Aaby Journal: Pediatrics Date: 2006-11 Impact factor: 7.124
Authors: Timothy F Feltes; Allison K Cabalka; H Cody Meissner; Franco M Piazza; David A Carlin; Franklin H Top; Edward M Connor; Henry M Sondheimer Journal: J Pediatr Date: 2003-10 Impact factor: 4.406
Authors: Deborah Dean; Lynne Neumayr; Dana M Kelly; Samir K Ballas; Klara Kleman; Shanda Robertson; Rathi V Iyer; Russell E Ware; Mabel Koshy; Wayne R Rackoff; Chuck H Pegelow; Peter Waldron; Lennette Benjamin; Elliott Vichinsky Journal: J Pediatr Hematol Oncol Date: 2003-01 Impact factor: 1.289